Instead, microdosing is considered an off-label practice
Glucagon-like peptide-1 (GLP-1) agonists are medications used to help individuals with Type 2 Diabetes (T2DM) and obesity
Because of that uncertainty, the FDA labelling recommends weighing the benefits of breastfeeding alongside the mother's need for Zepbound and any possible effects on the baby
What GLP-1 medications cannot do for Hashimoto's Managing expectations is important
As a result, many are choosing to: Limit access Prefer one drug over another Or remove coverage entirely for weight-loss use Medicare Changes Are Coming but Not in April There is a notable update for Medicare beneficiaries, but it doesnt begin until July 1, 2026
Why weight gain is common during menopause The menopausal transition is truly a metabolic transition, as hormonal shifts trigger changes in muscle mass, how the body stores fat, and insulin resistance